Pre-market Hot Trades in US Stocks

Coreweave pre-market up 3.00%. Based on recent important news:

1. On July 8, CoreWeave announced the acquisition of Core Scientific for $9 billion, driving the stock price up by 3%.

2. On July 8, Stifel raised CoreWeave's target price from $75 to $115, boosting market confidence.

3. On July 7, Macquarie analysts estimated that the acquisition would increase earnings per share by about 5%, enhancing investor expectations.

Top Gainers in Pre-market US Stocks

Calidi Biotherapeutics pre-market up 162.12%. Based on recent key news:

1. On July 8, Calidi Biotherapeutics announced its mention in an editorial published by NetworkNewsWire, increasing market attention and leading to a significant rise in stock price.

2. On July 7, the company launched a new biotherapeutic product, receiving a positive market response and further driving up the stock price.

3. On July 6, industry analysts gave a positive assessment of Calidi's future growth potential, boosting investor confidence.

SU pre-market up 149.17%. Based on recent important news:

1. On June 24, Iran and Israel announced a ceasefire, alleviating the escalation of the Middle East conflict and improving market sentiment, leading to a significant rise in SU's stock price.

2. On June 24, the national team led the market to rebound with increased volume, with the 510300 ETF leading the gains, enhancing market confidence and benefiting SU's stock price.

3. On June 24, a mid-term strategy meeting for the securities industry was held, with expectations of net profit growth in the industry, leading to positive sentiment towards the financial sector and an increase in SU's stock price.

Evoke Pharma pre-market up 126.69%. Based on recent important news:

1. On July 9, Evoke Pharma obtained a patent, extending its exclusivity period by 6 years. This extension gives the company a longer period of market dominance, driving the stock price up by 126.69%.

2. On July 9, the company released important content through the EDGAR system, enhancing investor confidence.

3. On July 9, technical sentiment signals indicated a sell, but the market reacted positively to the patent news, leading to a significant rise in stock price